Gonzalez-Rodriguez, E., Stoll, D., & Lamy, O. Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation. Wiley.
Chicago Style (17th ed.) CitationGonzalez-Rodriguez, Elena, Delphine Stoll, and Olivier Lamy. Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures After Denosumab Discontinuation. Wiley.
MLA (9th ed.) CitationGonzalez-Rodriguez, Elena, et al. Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures After Denosumab Discontinuation. Wiley.
Warning: These citations may not always be 100% accurate.